Redeye comments on Leqembi’s Q3 sales, disclosed earlier today in connection with Biogen’s quarterly...
Osäkerheten kring intäktströmmarna från försäljning av energisparcertifikat och uppdaterad värdering...
Verve Group’s Q324 update shows a further sequential quarterly step up in top-line growth to 31% as ...
Redeye provides a brief comment on Verve Group’s Q3 organic growth figure of 31%, up from 26% in Q2 ...
Finnair’s earnings continued to decline y/y in Q3, and although there’s now again potential for gain...
Loihde reported better than anticipated Q3 results, with sales growing 5% y/y to EUR 31.
Aspo’s Q3 EUR 8.7m comparable EBITA didn’t quite reach estimates, but in our opinion there remain ma...
LapWall’s Q3 was strong as the company was able to improve margins through volume growth leading to ...
Redeye sees that the y/y sales are disappointing, but considering the comparable quarter and its acc...
Pirepemat Ph 2b rolling towards topline IRL757 Ph 1 studies ongoing Webcast today at 10:00 CET Even...
Redeye updates on W5 Solutions following Q3-results which were weaker than expected while order inta...
Redeye updated its estimates and fair value range following Heliospctras Q3 2024 report, in which sa...
Net sales came 4% below consensus (LSEG) in Q3. The company's clean Q3 EBITA was 10% under our expec...
Redeye raises its Base Case slightly following a Q3 report showing a relatively strong performance i...
Redeye provides a brief comment on Nitro Games’ expansion of Autogun Heroes to CrazyGames, one of th...
Produktfördelar DUG potatisdrycker är klimatvänliga, hållbara och lämpar sig väl för veganer och pe...
Redeye takes a more positive stance towards Hexatronic following a Q3 report matching our expectatio...
Q2 momentum gone in Q3 Market to turn positive in '25, according to report We lower '25e EBITA by 13...
Beijer Alma levererar ett stabilt kvartal med viss organisk tillväxt trots en inbromsning i konjunkt...
Organic growth and earnings growth to remain high in Q4e Small estimate changes, adj.
